XML 39 R28.htm IDEA: XBRL DOCUMENT v3.4.0.3
Common Stock and Stockholders' Equity (Deficit) (Tables)
3 Months Ended
Mar. 31, 2016
Stockholders Equity [Abstract]  
Schedule of Redeemable Convertible Preferred Stock into Common Stock

As a result of this amendment, the redeemable convertible preferred stock became convertible into shares of common stock upon a qualifying event, including completion of an initial public offering, as follows:

 

Preferred Stock

 

Number of

Shares,

Actual

 

 

Conversion

Rate

 

 

Number of

Shares, As

Converted

 

Series A

 

 

1,319,940

 

 

 

1.0088

 

 

 

1,331,507

 

Series B

 

 

988,411

 

 

 

1.0148

 

 

 

1,003,071

 

Series C

 

 

4,019,524

 

 

 

1.0192

 

 

 

4,096,561

 

Series D

 

 

5,308,875

 

 

 

1.0218

 

 

 

5,424,802

 

Series E

 

 

2,439,058

 

 

 

1.0000

 

 

 

2,439,058

 

Series F

 

 

2,685,997

 

 

 

1.0000

 

 

 

2,685,997

 

Series G

 

 

3,692,684

 

 

 

1.0000

 

 

 

3,692,684

 

Total

 

 

20,454,489

 

 

 

 

 

 

 

20,673,680

 

 

Schedule of Restricted Stock Units Activity

A summary of the activity for the Company’s RSUs is presented below (in thousands, except per share amounts and contractual life years):

 

 

 

Number of

Shares

 

 

Weighted-

Average

Grant Date

Fair Value

(per share)

 

 

Weighted-

Average

Remaining

Contractual

Life (Years)

 

 

Aggregate

Intrinsic

Value

 

Unvested balance – December 31, 2015

 

 

 

 

$

 

 

 

 

 

$

 

Granted

 

 

404,938

 

 

 

13.39

 

 

 

 

 

 

 

 

Vested

 

 

(207,234

)

 

 

12.90

 

 

 

 

 

 

 

 

Forfeited

 

 

 

 

 

 

 

 

 

 

 

 

 

Unvested balance – March 31, 2016

 

 

197,704

 

 

$

13.91

 

 

 

4.2

 

 

$

2,635

 

Expected to vest – March 31, 2016

 

 

197,568

 

 

$

13.91

 

 

 

4.2

 

 

$

2,635

 

 

Schedule of Stock Option Activity

The following table summarizes the Company’s stock option activity for the three months ended March 31, 2016 (in thousands, except share and per share and contractual life amounts and years):

 

 

 

Options Outstanding

 

 

 

Number of

Shares

Underlying

Outstanding

Options

 

 

Weighted-

Average

Exercise Price

 

 

Weighted-

Average

Remaining

Contractual

Life (Years)

 

 

Aggregate

Intrinsic Value

 

Outstanding – December 31, 2015

 

 

4,311,463

 

 

$

9.87

 

 

 

7.9

 

 

$

22,709

 

Granted

 

 

513,569

 

 

 

13.77

 

 

 

10.0

 

 

 

 

 

Exercised

 

 

(102,050

)

 

 

2.96

 

 

 

 

 

 

 

 

Forfeited or cancelled

 

 

(75,036

)

 

 

11.99

 

 

 

 

 

 

 

 

Outstanding – March 31, 2016

 

 

4,647,946

 

 

$

10.41

 

 

 

8.0

 

 

$

15,959

 

Exercisable – March 31, 2016

 

 

2,176,598

 

 

$

7.10

 

 

 

6.7

 

 

$

14,001

 

Vested and expected to vest – March 31, 2016

 

 

4,553,559

 

 

$

10.35

 

 

 

7.9

 

 

$

15,909

 

 

Total intrinsic value of stock options exercised during the three months ended March 31, 2016 was $933,000.

 

Summary of Black-Scholes Option-Pricing Model to Determine Fair value of Stock Options

The following table summarizes the assumptions used in the Black-Scholes option-pricing model to determine the fair value of the Company’s stock options as follows:

 

 

 

Three months ended March 31,

 

 

 

2016

 

 

2015

 

Expected term (in years)

 

5.8

 

 

5.8

 

Expected volatility

 

 

45%

 

 

 

46%

 

Risk-free interest rate

 

1.3%-1.5%

 

 

 

1.4%

 

Dividend yield

 

 

0%

 

 

 

0%

 

 

Summary of Stock-Based Compensation Expenses

Total stock-based compensation expense was allocated as follows (in thousands):

 

 

 

Three months ended March 31,

 

 

 

2016

 

 

2015

 

Cost of revenue

 

$

215

 

 

$

100

 

Sales and marketing

 

 

583

 

 

 

541

 

Research and development

 

 

495

 

 

 

96

 

General and administrative

 

 

620

 

 

 

403

 

Total stock-based compensation expense

 

$

1,913

 

 

$

1,140